Epigenetic Downregulation of PTEN in Gallbladder Cancer
- 26.01.2017
- Brief Communication
- Verfasst von
- Dinesh Singh Tekcham
- Sanjeev Gupta
- Braj Raj Shrivastav
- Pramod Kumar Tiwari
- Erschienen in
- Journal of Gastrointestinal Cancer | Ausgabe 1/2017
Abstract
Purpose
Gallbladder cancer (GBC) is becoming a global health problem. Phosphatase and tensin homolog (PTEN), also known as guardian gene of cancer, encodes a protein, which dephosphorylates phosphatidylinositol (3,4,5) triphosphate {PtdIns (3,4,5) P3 } into phosphatidylinositol (4,5) diphosphate {PtdIns (4,5) P2} that results in the inhibition of AKT/PKB signaling pathway. PTEN plays a key role in the pathogenesis of various cancers. However, its role in GBC is still obscure. The present study was aimed to identify the epigenetic role of PTEN in GBC and GSD.
Methods
PTEN promoter methylation was studied by methylation-specific PCR in 50 GBC and 30 GSD tissues. Transcript level expression of PTEN was analyzed by reverse transcriptase PCR and quantitative PCR in 20 GBC and 20 GSD tissue samples. Immunohistochemistry was performed on tissue microarrays of 136 GBC samples to correlate the methylation pattern with the pattern of in situ expression of PTEN protein. Student’s t test was performed to test the significant level of difference between case and control samples. Values showing p ≤ 0.05 were considered significant.
Results
MS PCR showed PTEN promoter methylation in 30% (15/50) GBC (p = 0.0486) and 22.86% (8/30) GSD (p = 0.0530) cases. RT-PCR and qPCR revealed downregulation of PTEN in advanced GBC cases (p < 0.0001), but, not in GSD (p = 0.901). Immunohistochemistry of GBC tissue microarray scored 1+ in 20.29% (p = 0.0028) and zero or negative in 50% (p < 0.0001) GBC cores.
Conclusions
Thus, PTEN may be considered as a useful biomarker for the management of GBC, however, needs larger sample size to validate it further.
Anzeige
- Titel
- Epigenetic Downregulation of PTEN in Gallbladder Cancer
- Verfasst von
-
Dinesh Singh Tekcham
Sanjeev Gupta
Braj Raj Shrivastav
Pramod Kumar Tiwari
- Publikationsdatum
- 26.01.2017
- Verlag
- Springer US
- Erschienen in
-
Journal of Gastrointestinal Cancer / Ausgabe 1/2017
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636 - DOI
- https://doi.org/10.1007/s12029-017-9919-8
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.